Memorial Sloan Kettering Cancer Center

https://www.mskcc.org/healthcare-professionals

 

IDH Inhibitors in Myeloid Malignancies: What Are the Mechanisms of Resistance in R/R AML? What Are the Strategies to Combine IDH Inhibitors With SoC?

May 14, 2020

0 Comments
Login to view comments. Click here to Login
Leukemia